Each year, the American Cancer Society publishes data that gives a review of cancer statistics with foundational data that tells us about new cases in the U.S. and details on incidence and survival statistics state by state, overall and by cancer type. The latest report, which made headlines for a historic drop in cancer deaths, […]
In this Cancer Matters podcast, Dr Bill Nelson talks with Dr Julie Brahmer about the advances made in treating patients with lung cancer, smoking cessation and lung cancer screening.
In the next Cancer Disparities podcast, Dr Otis Brawley says that while #cancer screening is very important, focusing on prevention and ensuring adequate access to treatment for all Americans should remain top priorities. In this preview, Dr Brawley explains some of the geographical disparities that exist in the US and how they impact outcomes. To listen to […]
--This post was written by lung cancer expert Dr. Phillip Dennis. Lung cancer is the most deadly cancer in the United States and will kill over 200,000 Americans this year. Deaths from lung cancer exceed the number of deaths from breast cancer, prostate cancer, and colon cancer combined. The high mortality of lung cancer is […]
Prostate cancer topics abound in the latest Cancer News Review podcast. Dr. Bill Nelson, director of the Johns Hopkins Kimmel Cancer Center, discusses Hopkins-led research, published in the New England Journal of Medicine, looking at the genetic similarities of men with a family history of prostate cancer. By looking at their genes, investigators were able to find a genetic marker for […]
Recent news of the full results of the National Lung Screening Trial (NLST) published in the New England Journal of Medicine underscores the heavy toll that lung cancer takes on many lives. It's still the deadliest of all cancers. For Phyllis Curtis, who had enrolled in the trial at Johns Hopkins, the trial and screening […]
Starting in 2002, more than 50,000 current and former smokers aged 55 to 74 signed up for the National Lung Screening Trial (NLST) at Johns Hopkins and more than 30 other sites across the nation. The trial was to last 10 years, but eight years into the study, leaders of the trial found their results […]